Nanexa jumps 114% on up to €1.17 billion Novo Nordisk licensing deal

Nanexa shares rose 114% on September 25, 2026, after reports of a licensing deal with Novo Nordisk for injection technology worth up to about €1.17 billion ($1.33 billion). For savers and investors, that headline is a cap, not cash: payment depends on milestones yet to be met.